A/DT
low/JJ
NM23.H1/NN
gene/NN
expression/NN
identifying/VBG
high/JJ
malignancy/NN
human/JJ
melanomas/NNS
./.

The/DT
NM23/NN
gene/NN
has/VBZ
been/VBN
proposed/VBN
as/IN
a/DT
metastasis-suppressor/JJ
gene/NN
,/,
and/CC
its/PRP$
use/NN
has/VBZ
been/VBN
suggested/VBN
as/IN
prognostic/JJ
factor/NN
./.
=====
NM23/NN
was/VBD
identified/VBN
in/IN
a/DT
system/NN
of/IN
murine/NN
melanoma/NN
cell/NN
lines/NNS
,/,
in/IN
which/WDT
an/DT
inverse/JJ
relationship/NN
was/VBD
found/VBN
between/IN
NM23/CD
expression/NN
and/CC
metastatic/JJ
ability/NN
./.
=====
In/IN
a/DT
human/JJ
malignant/JJ
melanoma/NN
study/NN
NM23/NN
expression/NN
was/VBD
found/VBN
to/TO
be/VB
significantly/RB
lower/JJR
in/IN
metastases/NNS
that/WDT
developed/VBD
less/JJR
than/IN
24/CD
months/NNS
after/IN
diagnosis/NN
of/IN
the/DT
primary/JJ
tumours/NNS
./.
=====
The/DT
present/JJ
paper/NN
studies/VBZ
the/DT
expression/NN
of/IN
the/DT
NM23.H1/NN
gene/NN
in/IN
cell/NN
lines/NNS
which/WDT
derive/VBP
from/IN
primary/JJ
or/CC
metastatic/JJ
human/JJ
malignant/JJ
melanomas/NNS
in/IN
relation/NN
to/TO
staging/NN
,/,
infiltration/NN
degree/NN
,/,
lymphocytic/JJ
infiltration/NN
,/,
cell/NN
morphology/NN
,/,
cell/NN
pigmentation/NN
,/,
karyotype/NN
,/,
and/CC
disease-free/JJ
survival/NN
./.
=====
The/DT
level/NN
of/IN
mRNA/NN
expression/NN
of/IN
the/DT
NM23/NN
gene/NN
is/VBZ
significantly/RB
lower/JJR
in/IN
cell/NN
lines/NNS
that/WDT
derive/VBP
from/IN
more/JJR
infiltrating/VBG
primary/JJ
melanomas/NNS
than/IN
in/IN
cell/NN
lines/NNS
obtained/VBN
from/IN
less/RBR
infiltrating/JJ
tumours/NNS
./.
=====
Moreover/RB
,/,
cell/NN
lines/NNS
derived/VBN
from/IN
tumours/NNS
of/IN
patients/NNS
with/IN
a/DT
disease-free/JJ
survival/NN
of/IN
more/JJR
than/IN
24/CD
months/NNS
(/(
24-58/CD
months/NNS
)/)
express/VBP
the/DT
NM23/NN
gene/NN
at/IN
higher/JJR
levels/NNS
than/IN
cell/NN
lines/NNS
obtained/VBN
from/IN
melanomas/NNS
of/IN
patients/NNS
with/IN
a/DT
disease-free/JJ
survival/NN
of/IN
less/JJR
than/IN
24/CD
months/NNS
(/(
6-15/CD
months/NNS
)/)
./.